Our Pricing

Tirzepatide Next Day Delivery - Order Online Today

Published on: June 03, 2026

Need tirzepatide next day delivery UK with a trusted online pharmacy? Cured Pharmacy offers genuine UK-licensed Mounjaro (tirzepatide) from £124.99 with free clinical consultation by UK prescribers and discreet next-day delivery across the UK. Our transparent pricing means you'll see the exact cost before your consultation, and our GPhC-registered team ensures every prescription is clinically appropriate for your weight loss journey.

How Tirzepatide Works for Weight Loss

Tirzepatide is the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway medications, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing enhanced effects on appetite regulation, insulin sensitivity, and energy expenditure.

In the landmark SURPASS-2 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly outperforming semaglutide 1mg in head-to-head comparison [1]. The dual receptor mechanism appears to enhance satiety signals more effectively than GLP-1 agonism alone, whilst also improving glycaemic control in patients with type 2 diabetes [2].

Tirzepatide works by slowing gastric emptying, reducing appetite through central nervous system pathways, and improving insulin secretion in response to meals. Most patients report feeling fuller for longer periods and experiencing reduced food cravings within the first few weeks of treatment, though individual responses vary and clinical supervision is essential throughout.

Tirzepatide Next Day Delivery Service at Cured Pharmacy

Our tirzepatide next day delivery UK service operates Monday to Friday, with orders approved before 3pm dispatched the same day for next-day arrival. Weekend orders are processed on Monday morning. All deliveries require a signature to ensure secure receipt of your prescription medication.

Cured Pharmacy stocks genuine Mounjaro KwikPen devices manufactured by Eli Lilly — the only UK-licensed tirzepatide product currently available. We guarantee lowest prices in the UK, with transparent upfront pricing displayed before you begin your consultation. No hidden fees, no subscription traps, and no pressure to continue treatment beyond what's clinically recommended.

Our Prescription Process

Every tirzepatide prescription at Cured Pharmacy begins with a free online consultation that typically takes under 3 minutes to complete. Our UK-registered prescribers review your medical history, current medications, weight loss goals, and any contraindications before approving treatment. This isn't a tick-box exercise — superintendent pharmacist Tarun Kumar (GPhC 2233073) and our clinical team assess each case individually to ensure tirzepatide is clinically appropriate and safe for you.

Once approved, your prescription is dispensed from our GPhC-registered pharmacy (registration 9012511) and dispatched via next-day courier in 100% discreet packaging. We use plain, unmarked boxes with no pharmacy branding or medication details visible externally, ensuring complete privacy. Track your order in real-time and receive it at your chosen address within 24 hours of approval.

Mounjaro Dosing Schedule and What to Expect

Most patients reach their maintenance dose between 10mg and 15mg weekly, though some achieve their weight loss goals at lower doses. The SURMOUNT-1 trial demonstrated dose-dependent weight reduction, with higher doses producing greater average weight loss, but individual responses vary considerably [4]. Your prescriber will work with you to find the minimum effective dose that achieves your clinical goals whilst minimising side effects.

Injections are self-administered subcutaneously in the abdomen, thigh, or upper arm using the pre-filled Mounjaro KwikPen. Each pen contains a single dose, and you'll inject once weekly on the same day each week. Detailed injection technique guidance is provided with your first prescription, and our pharmacy team is available by phone if you have questions during treatment.

Titration Protocol

Tirzepatide follows a structured dose escalation schedule to minimise gastrointestinal side effects whilst optimising weight loss outcomes. Treatment begins at 2.5mg once weekly for the first four weeks, serving as an initial tolerability dose rather than a therapeutic dose [3]. Your prescriber will then increase to 5mg weekly, with further escalations to 7.5mg, 10mg, 12.5mg, or 15mg at four-week intervals based on your response and tolerability.

This gradual titration is essential — jumping to higher doses too quickly significantly increases the risk of nausea, vomiting, and treatment discontinuation. Clinical trials used this exact escalation protocol, and deviating from it may compromise both safety and effectiveness [3]. Your UK prescriber will guide you through each dose change and monitor for any adverse effects requiring adjustment.

Tirzepatide vs Other Weight Loss Medications

When comparing weight loss treatments available through UK pharmacies, tirzepatide consistently demonstrates superior efficacy in clinical trials. The SURPASS-2 head-to-head trial showed tirzepatide 15mg produced 22.5% average weight reduction compared to 16.8% with semaglutide 1mg over 72 weeks [1]. This represents a clinically meaningful difference for patients seeking maximum weight loss outcomes.

Semaglutide-based treatments like Wegovy work through GLP-1 receptor agonism alone, whilst tirzepatide's dual GIP/GLP-1 mechanism appears to enhance both weight loss and metabolic improvements. Both medications require once-weekly injection and follow similar dose escalation protocols, though tirzepatide's titration schedule extends to higher maximum doses. Cost considerations, individual tolerability, and specific medical history all influence which treatment your prescriber recommends.

Older options like liraglutide (Saxenda) require daily injections and produce more modest weight loss outcomes, whilst oral medications such as orlistat work through fat absorption inhibition rather than appetite regulation. For patients seeking the most effective injectable treatment currently licensed in the UK, tirzepatide represents the gold standard based on available clinical evidence, though individual suitability varies and requires professional assessment.

Common Side Effects and How to Manage Them

Less common but more serious side effects include pancreatitis (severe abdominal pain radiating to the back), gallbladder problems, and hypoglycaemia in patients taking other diabetes medications. Tirzepatide carries a boxed warning in the US regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [5]. Nevertheless, tirzepatide is contraindicated in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Your prescriber will review your complete medical history during consultation to identify any contraindications or risk factors requiring additional monitoring. Report any persistent severe abdominal pain, visual changes, rapid heartbeat, or signs of allergic reaction immediately. Most patients tolerate tirzepatide well when the dose escalation protocol is followed appropriately and clinical guidance is maintained throughout treatment.

Gastrointestinal Effects

The most frequently reported side effects of tirzepatide are gastrointestinal in nature, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [3]. These effects typically occur during dose escalation and often diminish as your body adjusts to each new dose level. In clinical trials, most gastrointestinal side effects were mild to moderate in severity and resolved within several weeks.

Practical strategies to minimise nausea include eating smaller, more frequent meals rather than large portions, avoiding high-fat or spicy foods, staying well-hydrated, and taking your injection in the evening so peak effects occur during sleep. If nausea persists or worsens, contact your prescriber — they may recommend slowing your dose escalation or remaining at your current dose for an additional four weeks before increasing further.

Who Can Use Tirzepatide for Weight Loss

Tirzepatide should be used as part of a comprehensive weight management programme including reduced-calorie diet and increased physical activity. Clinical trials enrolled participants who received lifestyle intervention counselling alongside medication, and real-world effectiveness depends on maintaining these behavioural changes throughout treatment [4]. Your prescriber may recommend stopping tirzepatide if you haven't achieved at least 5% weight loss after 16 weeks at the maximum tolerated dose.

At Cured Pharmacy, our UK-registered prescribers conduct thorough assessments to ensure tirzepatide is clinically appropriate for your individual circumstances. We don't approve prescriptions automatically — each consultation is reviewed by a qualified healthcare professional who considers your medical history, current medications, and weight loss goals before making a prescribing decision. This clinical rigour protects patient safety whilst ensuring those who are suitable can access treatment quickly with next-day delivery.

Eligibility Criteria

Tirzepatide is licensed in the UK for chronic weight management in adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidaemia [5]. Your prescriber will calculate your BMI during consultation and assess whether you meet the clinical criteria for treatment.

Tirzepatide is not suitable for everyone. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, previous serious hypersensitivity to tirzepatide, pregnancy, and breastfeeding. Caution is required in patients with severe gastrointestinal disease, history of pancreatitis, diabetic retinopathy, or renal impairment [5]. Your prescriber will evaluate these factors before approving treatment.

Scientific References

1. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14881 [accessed 13 August 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
5. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro (tirzepatide): UK Public Assessment Report. Retrieved from https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Tirzepatide is a prescription-only medicine and may not be suitable for everyone. Individual results vary and weight loss outcomes depend on adherence to a reduced-calorie diet and increased physical activity alongside medication. Never stop or change your prescribed treatment without consulting your healthcare provider.